Recombinant multi-species NMI protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NMI protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
NMYC interactor (NMI) encodes a protein that interacts with NMYC and CMYC (two members of the oncogene Myc family), and other transcription factors containing a Zip, HLH, or HLH-Zip motif. The NMI protein also interacts with all STATs except STAT2 and augments STAT-mediated transcription in response to cytokines IL2 and IFN-gamma. The NMI mRNA has low expression levels in all human fetal and adult tissues tested except brain and has high expression in cancer cell line-myeloid leukemias. [provided by RefSeq, Jul 2008]
The Alternative Names of target: N-myc and STAT interactor,N-myc-interactor,NMI,Nmi
Go
to NMI products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-SE1126-Ag-1/ GM-Tg-hg-SE1126-Ag-2 | Human NMI protein | Human |
| GM-Tg-rg-SE1126-Ag-1/ GM-Tg-rg-SE1126-Ag-2 | Rat NMI protein | Rat |
| GM-Tg-mg-SE1126-Ag-1/ GM-Tg-mg-SE1126-Ag-2 | Mouse NMI protein | Mouse |
| GM-Tg-cynog-SE1126-Ag-1/ GM-Tg-cynog-SE1126-Ag-2 | Cynomolgus/Rhesus macaque NMI protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-SE1126-Ag-1/ GM-Tg-felg-SE1126-Ag-2 | Feline NMI protein | Feline |
| GM-Tg-cang-SE1126-Ag-1/ GM-Tg-cang-SE1126-Ag-2 | Canine NMI protein | Canine |
| GM-Tg-bovg-SE1126-Ag-1/ GM-Tg-bovg-SE1126-Ag-2 | Bovine NMI protein | Bovine |
| GM-Tg-equg-SE1126-Ag-1/ GM-Tg-equg-SE1126-Ag-2 | Equine NMI protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-SE1126-Ag-1/ GM-Tg-hg-SE1126-Ag-2;
GM-Tg-rg-SE1126-Ag-1/ GM-Tg-rg-SE1126-Ag-2;
GM-Tg-mg-SE1126-Ag-1/ GM-Tg-mg-SE1126-Ag-2; GM-Tg-cynog-SE1126-Ag-1/ GM-Tg-cynog-SE1126-Ag-2; GM-Tg-felg-SE1126-Ag-1/ GM-Tg-felg-SE1126-Ag-2; GM-Tg-cang-SE1126-Ag-1/ GM-Tg-cang-SE1126-Ag-2; GM-Tg-bovg-SE1126-Ag-1/ GM-Tg-bovg-SE1126-Ag-2; GM-Tg-equg-SE1126-Ag-1/ GM-Tg-equg-SE1126-Ag-2 |
| Products Name | NMI protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | NMI |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NMI protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.